Ubs Group Ag Anika Therapeutics, Inc. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 14,052 shares of ANIK stock, worth $168,342. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,052

Previous 68,724 79.55%

Holding current value

$168,342

Previous $1.13 Million 81.34%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$15.03 - $17.97 $821,720 - $982,455	-54,672 Reduced 79.55%	14,052 $211,000
Q4 2024 Feb 14, 2025	BUY	$16.04 - $25.53 $981,391 - $1.56 Million	61,184 Added 811.46%	68,724 $1.13 Million
Q3 2024 Nov 14, 2024	BUY	$24.25 - $28.75 $10,936 - $12,966	451 Added 6.36%	7,540 $186,000
Q2 2024 Aug 13, 2024	SELL	$24.57 - $28.47 $285,994 - $331,390	-11,640 Reduced 62.15%	7,089 $179,000
Q1 2024 May 13, 2024	BUY	$21.95 - $26.42 $74,256 - $89,378	3,383 Added 22.04%	18,729 $475,000
Q4 2023 Feb 09, 2024	BUY	$18.47 - $23.3 $110,265 - $139,101	5,970 Added 63.67%	15,346 $347,000
Q3 2023 Nov 09, 2023	SELL	$16.98 - $26.1 $237,091 - $364,434	-13,963 Reduced 59.83%	9,376 $174,000
Q2 2023 Aug 11, 2023	BUY	$25.16 - $28.86 $85,367 - $97,921	3,393 Added 17.01%	23,339 $606,000
Q1 2023 May 12, 2023	SELL	$25.91 - $32.1 $128,617 - $159,344	-4,964 Reduced 19.93%	19,946 $572,000
Q4 2022 Feb 08, 2023	BUY	$23.85 - $31.91 $456,226 - $610,406	19,129 Added 330.89%	24,910 $737,000
Q3 2022 Nov 10, 2022	BUY	$21.74 - $24.68 $17,935 - $20,361	825 Added 16.65%	5,781 $137,000
Q2 2022 Aug 10, 2022	SELL	$20.4 - $25.53 $493,822 - $618,004	-24,207 Reduced 83.01%	4,956 $110,000
Q1 2022 May 16, 2022	SELL	$24.7 - $36.54 $15,141 - $22,399	-613 Reduced 2.06%	29,163 $732,000
Q4 2021 Feb 14, 2022	BUY	$35.83 - $45.03 $334,616 - $420,535	9,339 Added 45.7%	29,776 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$38.75 - $44.47 $399,977 - $459,019	10,322 Added 102.05%	20,437 $870,000
Q2 2021 Aug 13, 2021	SELL	$39.42 - $48.08 $372,519 - $454,356	-9,450 Reduced 48.3%	10,115 $438,000
Q1 2021 May 12, 2021	BUY	$32.49 - $45.96 $603,631 - $853,890	18,579 Added 1884.28%	19,565 $798,000
Q4 2020 Feb 11, 2021	SELL	$32.59 - $45.26 $36,728 - $51,008	-1,127 Reduced 53.34%	986 $45,000
Q3 2020 Nov 12, 2020	BUY	$32.56 - $38.57 $30,541 - $36,178	938 Added 79.83%	2,113 $75,000
Q2 2020 Jul 31, 2020	SELL	$27.83 - $37.73 $159,772 - $216,607	-5,741 Reduced 83.01%	1,175 $44,000
Q1 2020 May 01, 2020	BUY	$22.38 - $54.06 $70,631 - $170,613	3,156 Added 83.94%	6,916 $200,000
Q4 2019 Feb 14, 2020	SELL	$51.85 - $73.36 $1.74 Million - $2.46 Million	-33,524 Reduced 89.92%	3,760 $195,000
Q3 2019 Nov 14, 2019	BUY	$40.05 - $57.47 $757,305 - $1.09 Million	18,909 Added 102.91%	37,284 $2.05 Million
Q2 2019 Aug 14, 2019	SELL	$30.3 - $41.14 $2.75 Million - $3.73 Million	-90,757 Reduced 83.16%	18,375 $747,000
Q1 2019 May 14, 2019	BUY	$29.37 - $40.49 $1.11 Million - $1.52 Million	37,662 Added 52.7%	109,132 $3.3 Million
Q4 2018 Feb 14, 2019	BUY	$30.16 - $43.0 $259,858 - $370,488	8,616 Added 13.71%	71,470 $2.4 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $42.51 $352,430 - $456,344	10,735 Added 20.6%	62,854 $2.65 Million
Q2 2018 Aug 14, 2018	BUY	$28.77 - $48.27 $1.41 Million - $2.37 Million	49,026 Added 1585.06%	52,119 $1.67 Million
Q1 2018 May 15, 2018	SELL	$49.22 - $68.43 $81,705 - $113,593	-1,660 Reduced 34.93%	3,093 $154,000
Q4 2017 Feb 14, 2018	BUY	$52.14 - $59.94 $114,134 - $131,208	2,189 Added 85.37%	4,753 $256,000
Q3 2017 Nov 14, 2017	BUY	$51.16 - $58.21 $38,728 - $44,064	757 Added 41.89%	2,564 $148,000
Q2 2017 Aug 14, 2017	BUY	N/A	86 Added 5.0%	1,807 $89,000
Q1 2017 Nov 14, 2017	BUY	N/A	1,721	1,721 $75,000

Others Institutions Holding ANIK

# of Institutions

112

Shares Held

11.3M

Call Options Held

1.2K

Put Options Held

1.4K

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $175M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account